WeVote

Bill

Bill

HF 2489

Epinephrine access in schools requirements modified.

2025-2026 Regular Session Introduced by Ben Bakeberg and 9 co-sponsors

HF 2489 modifies school epinephrine access requirements, adjusting protocols for stocking, staff training, and emergency administration of auto-injectors during anaphylactic reactions.

Author added Kraft
0
WeVote Research Nonpartisan
Bill Summary · HF 2489

Legislative bill overview

HF 2489 modifies Minnesota's requirements for epinephrine access and administration in schools. The bill adjusts existing protocols for how schools must stock, train staff on, and deploy epinephrine auto-injectors (EpiPens) for students experiencing anaphylactic emergencies.

Why is this important

Anaphylaxis is a life-threatening allergic reaction that requires immediate epinephrine administration—delays of even minutes can be fatal. Schools are critical locations where children spend significant time and may experience severe allergic reactions, making clear, consistent epinephrine access protocols essential for student safety.

Potential points of contention

  • Scope of access: Questions about whether schools should stock epinephrine for all students or only those with known allergies, and whether undesignated auto-injectors create liability concerns
  • Training and liability: Disagreement over what level of staff training is required, who can administer epinephrine, and whether schools face legal exposure for administration decisions
  • Implementation costs: School districts may resist requirements that impose budget burdens for purchasing, storage, training, and potential replacement of expired medications

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.